European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

G Raverot, P Burman, A McCormack… - European journal of …, 2018 - academic.oup.com
Background Pituitary tumours are common and easily treated by surgery or medical
treatment in most cases. However, a small subset of pituitary tumours does not respond to …

Management of endocrine disease: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion

J Young, M Haissaguerre, O Viera-Pinto… - European journal of …, 2020 - academic.oup.com
Ectopic ACTH syndrome (EAS) is rare but is frequently a severe condition because of the
intensity of the hypercortisolism that may be dissociated from the tumoral condition. EAS …

Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation

MS Hofman, WFE Lau, RJ Hicks - Radiographics, 2015 - pubs.rsna.org
Gallium 68 (68Ga) 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA)–
octreotate (DOTATATE, GaTate) positron emission tomography (PET)/computed tomography …

Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT

Y Sanli, I Garg, A Kandathil, T Kendi… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to provide a review of the use of 68Ga
tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a …

68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours

R Sharma, WM Wang, S Yusuf, J Evans… - Radiotherapy and …, 2019 - Elsevier
Purpose [177 Lu] DOTATATE prolongs progression free survival (PFS) in metastatic
neuroendocrine tumours (NETs). However, objective response rate is low. This, coupled …

Diagnosis, management and theragnostic approach of gastro-entero-pancreatic neuroendocrine neoplasms

L Piscopo, E Zampella, S Pellegrino, F Volpe, C Nappi… - Cancers, 2023 - mdpi.com
Simple Summary Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) are the
most common neuroendocrine tumors, with the ability of overexpressing somatostatin …

The Utility of 68Ga-DOTATATE Positron-Emission Tomography/Computed Tomography in the Diagnosis, Management, Follow-Up and Prognosis of Neuroendocrine …

A Tirosh, E Kebebew - Future Oncology, 2017 - Taylor & Francis
Neuroendocrine tumors (NETs) are rare neoplasms that emerge mainly from the GI tract,
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …

Gallium-68 in medical imaging

L Martiniova, LD Palatis, E Etchebehere… - Current …, 2016 - ingentaconnect.com
Over the past several years, Positron Emission Tomography (PET) imaging agents labeled
with 68Gallium (68Ga) have undergone a significant increase in clinical utilization. 68Ga is …

Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic …

DH Simsek, S Kuyumcu, C Turkmen… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Gastroenteropancreatic neuroendocrine tumors (GEPNETs) are indolent neoplasms
presenting unpredictable and unusual biologic behavior that causes many clinical …

SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: a proposed standardization framework

RA Werner, LB Solnes, MS Javadi… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Reliable standards and criteria for somatostatin receptor (SSTR) PET are still lacking. We
herein propose a structured reporting system on a 5-point scale for SSTR PET imaging, titled …